Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Agenda Slates September For Cough/Cold Proposal, Sunscreen Rule

This article was originally published in The Tan Sheet

Executive Summary

Meeting deadlines on regulatory agenda actions, such as finalizing OTC monographs, could be a higher priority for FDA under its new management
Advertisement

Related Content

OTC cough/cold dosing proposal on FDA agenda
Estee Lauder's SolarSmart Sunscreen Line Emphasizes UVB-To-UVA Ratio
FDA Amends OTC Oral Sodium Phosphate Labeling, Warns Of Risks
FDA Deems UVA Filter Ecamsule Eligible For Monograph Inclusion, Seeks Data
FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off
FDA Call For Pediatric Cough/Cold Input Signals New Rule Is A Long Way Off
FDA Panel Narrowly Votes Against Cough/Cold Drugs For Children Up To Age 6
FDA Review Of Children’s Cough/Cold OTCs Has Broader Implications
Official PPA Removal From Market Sought In FDA Proposed Rule
OTC Bronchodilators With Ephedrine Permitted In New Proposed Rule

Topics

Advertisement
UsernamePublicRestriction

Register

PS102945

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel